Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Block

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cephalalgia : an International Journal of Headache|July 14, 1999
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study GroupS P Ahrens, M V Farmer, D L Williams, et al.
British Journal of Clinical Pharmacology|March 1, 1993
The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemiaS A Eckernäs, B E Roos, P Kvidal, et al.
Headache|April 4, 2001
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study GroupP Tfelt-Hansen, J Teall, F Rodriguez, et al.
Neurology|January 14, 2004
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled studyS A Reines, G A Block, J C Morris, et al.
Clinical Neuropharmacology|August 1, 1991
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter studyW C Koller, G A Block, J E Ahlskog, et al.
Clinical Nephrology|August 21, 2007
Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidismJ R Sterrett, J Strom, H K Stummvoll, et al.
Journal of Human Hypertension|June 5, 2015
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trialT I Chang, S Abdalla, G M London, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cephalalgia : an International Journal of Headache|July 14, 1999
Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study GroupS P Ahrens, M V Farmer, D L Williams, et al.
British Journal of Clinical Pharmacology|March 1, 1993
The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemiaS A Eckernäs, B E Roos, P Kvidal, et al.
Headache|April 4, 2001
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study GroupP Tfelt-Hansen, J Teall, F Rodriguez, et al.
Neurology|January 14, 2004
Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled studyS A Reines, G A Block, J C Morris, et al.
Clinical Neuropharmacology|August 1, 1991
Effect of MK-458 (HPMC) in Parkinson's disease previously untreated with dopaminergic drugs. A double-blind, placebo-controlled multicenter studyW C Koller, G A Block, J E Ahlskog, et al.
Clinical Nephrology|August 21, 2007
Cinacalcet HCI (Sensipar/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidismJ R Sterrett, J Strom, H K Stummvoll, et al.
Journal of Human Hypertension|June 5, 2015
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trialT I Chang, S Abdalla, G M London, et al.
Pageof 3